SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,826,008 | +205.6% | 102,503 | +233.2% | 0.01% | +250.0% |
Q2 2023 | $924,616 | -45.7% | 30,759 | -51.9% | 0.00% | -63.6% |
Q3 2021 | $1,704,000 | +13.6% | 63,894 | +11.5% | 0.01% | 0.0% |
Q1 2021 | $1,500,000 | -54.2% | 57,283 | -56.0% | 0.01% | -59.3% |
Q4 2020 | $3,275,000 | +4.9% | 130,168 | -13.1% | 0.03% | +3.8% |
Q3 2020 | $3,122,000 | -8.1% | 149,800 | +4.8% | 0.03% | -33.3% |
Q2 2020 | $3,396,000 | +40.5% | 143,001 | +6.4% | 0.04% | -43.5% |
Q1 2020 | $2,417,000 | +43.0% | 134,339 | +88.6% | 0.07% | +109.1% |
Q4 2019 | $1,690,000 | +225.6% | 71,229 | +277.1% | 0.03% | +266.7% |
Q3 2019 | $519,000 | -53.2% | 18,888 | -43.6% | 0.01% | -71.0% |
Q2 2019 | $1,109,000 | +7.4% | 33,516 | +13.7% | 0.03% | 0.0% |
Q1 2019 | $1,033,000 | -23.9% | 29,479 | -27.8% | 0.03% | -50.0% |
Q4 2018 | $1,357,000 | -32.8% | 40,842 | +21.0% | 0.06% | +14.8% |
Q2 2018 | $2,020,000 | +59.3% | 33,753 | +14.8% | 0.05% | +68.8% |
Q2 2017 | $1,268,000 | – | 29,412 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |